fashion -WSS

fashion

author：fashion 2025-10-01 00:47:23 - browse：9

Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.

For more on what we cover, here’s the latest on artificial womb technology; here’s more on the ALS debate; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Cancer drug shortages should be causing more outrage
Next article： In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

WSS

How many hemophilia patients actually want gene therapy?

HHS secretary Becerra pressed on Change HealthCare cyberattack

FDA clears Verve to begin U.S. study of gene

As AI in medicine takes off, can 'human in the loop' prevent harm?

Smaller biotechs seek to piggyback on weight loss drug boom

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

hotspot

fashion

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

How AI can help patients find reliable information about doctors

23andMe had bad news about my health. I wish a person had delivered it

Study on Amgen’s bispecific immunotherapy produces positive data

Medicare proposal to cover medical devices draws a mixed reaction

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

ChatGPT in medicine: STAT answers readers' burning questions

HHS secretary Becerra pressed on Change HealthCare cyberattack

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Boston's new lab space is opening empty

focus

Questions loom on AstraZeneca cancer drug as safety concerns ebb

STAT Readout Newsletter: Biotech news today

RaDonda Vaught links Vanderbilt hospital issues to patient death

Male and female sex labels in research insufficient, scientists say

Results on Novartis prostate cancer therapy could expand its use

UnitedHealth, Optum discontinue NaviHealth name

explore

hotspot

entertainment

entertainment